Valuation: Rohto Pharmaceutical Co.,Ltd.

Market Cap 549B 3.4B 2.97B 2.74B 2.53B 4.81B 324B 4.89B 32.77B 12.87B 160B 12.76B 12.49B P/E 2027 *
15.7x
P/E 2028 * 14.9x
Enterprise Value 496B 3.07B 2.68B 2.48B 2.29B 4.34B 293B 4.41B 29.58B 11.62B 144B 11.52B 11.27B EV / Sales 2027 *
1.35x
EV / Sales 2028 * 1.22x
Free-Float
85.98%
Yield 2027 *
2.04%
Yield 2028 * 2.07%
1 day-1.42%
1 week+1.02%
Current month+1.80%
1 month+0.70%
3 months-1.26%
6 months-5.70%
Current year-7.53%
1 week 2,371.5
Extreme 2371.5
2,560
1 month 2,258
Extreme 2258
2,560
Current year 2,218.5
Extreme 2218.5
2,701
1 year 2,040.5
Extreme 2040.5
2,703
3 years 1,964.5
Extreme 1964.5
4,117
5 years 1,433.5
Extreme 1433.5
4,117
10 years 762
Extreme 762
4,117
Manager TitleAgeSince
Chief Executive Officer 70 2019-05-31
President 64 2025-06-25
Director of Finance/CFO 62 2022-02-28
Director TitleAgeSince
Chairman 70 2009-05-31
Director/Board Member 70 2010-05-31
Director/Board Member 62 2011-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.42%+1.02%+19.29%-20.64% 3.4B
-2.33%-2.09%+50.33%+162.29% 1,060B
-0.82%-2.30%+62.97%+61.11% 619B
-0.73%-4.98%+27.22%+84.46% 438B
+0.33%-1.17%+27.98%+26.90% 333B
-0.02%-2.85%+25.27%+44.88% 282B
-3.89%-11.22%+20.78%+26.07% 267B
+0.66%-1.42%-29.26%-39.30% 218B
-0.06%-2.88%+20.98%+61.70% 196B
-3.72%-1.10%+13.35%+71.53% 161B
Average -0.95%-2.82%+23.89%+47.90% 357.73B
Weighted average by Cap. -0.57%-2.95%+35.27%+81.17%

Financials

2027 *2028 *
Net sales 368B 2.28B 1.99B 1.84B 1.7B 3.22B 217B 3.27B 21.96B 8.62B 107B 8.55B 8.37B 384B 2.38B 2.08B 1.92B 1.77B 3.36B 227B 3.42B 22.9B 8.99B 112B 8.92B 8.73B
Net income 35.07B 217M 190M 175M 162M 307M 20.71B 312M 2.09B 822M 10.2B 815M 798M 36.81B 228M 199M 184M 170M 322M 21.74B 328M 2.2B 863M 10.71B 856M 837M
Net Debt -53.4B -331M -289M -267M -246M -467M -31.53B -475M -3.19B -1.25B -15.53B -1.24B -1.21B -80.89B -501M -438M -404M -373M -708M -47.76B -720M -4.83B -1.9B -23.53B -1.88B -1.84B
Logo Rohto Pharmaceutical Co.,Ltd.
Rohto Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of eye care (eye drops, eyewash), skin care (external medications, lip balm, sunscreen, functional cosmetics), oral medication (gastrointestinal medicines, herbal medicines, supplements), and other products and services (in vitro diagnostic reagents) in the health and beauty care field. The Company operates through four regional segments. The Japan segment manufactures and sells eye care, skin care, oral medication, and other products (services). The Americas segment and the Europe segment mainly manufacture and sell skin care products (services). The Asia segment mainly manufactures and sells eye care and skin care products (services), as well as oral medication products (services).
Employees
9,292
Date Price Change Volume
26-07-10 JP¥2,430.00 -1.42% 770,600
26-07-09 JP¥2,465.00 -0.70% 605,300
26-07-08 JP¥2,482.50 -1.70% 814,900
26-07-07 JP¥2,525.50 +4.94% 1,748,800
26-07-06 JP¥2,406.50 +0.04% 728,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
2,430.00JPY
Average target price
2,941.82JPY
Spread / Average Target
+21.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4527 Stock